Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H16 |
| Molecular Weight | 136.234 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1C2CC3CC1CC(C2)C3
InChI
InChIKey=ORILYTVJVMAKLC-UHFFFAOYSA-N
InChI=1S/C10H16/c1-7-2-9-4-8(1)5-10(3-7)6-9/h7-10H,1-6H2
| Molecular Formula | C10H16 |
| Molecular Weight | 136.234 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramides. | 2002-12-15 |
|
| FTIR spectra and normal-mode analysis of a tetranuclear manganese adamantane-like complex in two electrochemically prepared oxidation states: relevance to the oxygen-evolving complex of photosystem II. | 2002-09-18 |
|
| 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase. | 2002-09-12 |
|
| H-coupled electron transfer in alkane C-h activations with halogen electrophiles. | 2002-09-11 |
|
| Metal-switching and self-inclusion of functional cavitands. | 2002-09-04 |
|
| Fluorescent probes for cytochrome p450 structural characterization and inhibitor screening. | 2002-09-04 |
|
| Stimulation of TNF-alpha production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) - a novel immunomodulator with potential application in tumour immunotherapy. | 2002-09 |
|
| New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. | 2002-07-01 |
|
| Neurotensin phase-shifts the firing rate rhythm of neurons in the rat suprachiasmatic nuclei in vitro. | 2002-07 |
|
| Mechanism of asymmetric hydrogenation by rhodium complexes with unsymmetrical P-chirogenic bisphosphine ligands. | 2002-07 |
|
| Structural properties of a series of photochromic fluorinated indolylfulgides. | 2002-07 |
|
| Unique dual fluorescence of sterically congested hexaalkyl benzenehexacarboxylates: mechanism and application to viscosity probing. | 2002-06-19 |
|
| Comprehensive study of the methyl effect on the solvolysis rates of bridgehead derivatives. | 2002-06-12 |
|
| Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones. | 2002-06-06 |
|
| Novel selective PDE4 inhibitors. 3. In vivo antiinflammatory activity of a new series of N-substituted cis-tetra- and cis-hexahydrophthalazinones. | 2002-06-06 |
|
| Evaluation of GluR2 subunit involvement in AMPA receptor function of neonatal rat hypoglossal motoneurons. | 2002-06 |
|
| The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area. | 2002-06 |
|
| Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD). | 2002-06 |
|
| Dimethyladamantylmaleimide-induced in vitro and in vivo growth inhibition of human colon cancer Colo205 cells. | 2002-06 |
|
| [Comparison of anti-amnesia properties of NMDA-receptor "fast" blockers and polyamines]. | 2002-05-25 |
|
| Development of a nonviral gene delivery vehicle for systemic application. | 2002-05-16 |
|
| New dendrimer-peptide host-guest complexes: towards dendrimers as peptide carriers. | 2002-05-03 |
|
| A preliminary approach to nonenolizable beta,beta-tricarbonyls: assembly of a hyperevolutin prototype. | 2002-05-03 |
|
| Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats. | 2002-05 |
|
| Synthesis, structure and tumour necrosis factor-alpha production-enhancing properties of novel adamantylamino heterocyclic derivatives. | 2002-04-19 |
|
| Triorganostannylation of halo- and dihaloadamantanes and 5-chloro-2-adamantanone in liquid ammonia by the S(RN)1 mechanism. Relative reactivity of nucleophiles and bridgehead halides. | 2002-04-19 |
|
| Structural characteristics of ionotropic glutamate receptors as identified by channel blockade. | 2002-04-11 |
|
| Acetylide-bridged organometallic oligomers via the photochemical metathesis of methyl-iron(II) complexes. | 2002-04-10 |
|
| Pairwise exchanges of oxo and imido groups in rhenium(VII) compounds. | 2002-04-08 |
|
| Adamantyl tenocyclidines--adjuvant therapy in poisoning with organophosphorus compounds and carbamates. | 2002-04 |
|
| The estrogen receptor is not essential for all estrogen neuroprotection: new evidence from a new analog. | 2002-04 |
|
| The estimation of melting points and fusion enthalpies using experimental solubilities, estimated total phase change entropies, and mobile order and disorder theory. | 2002-03-26 |
|
| Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part II: alkylation far away from the amino function. | 2002-03-25 |
|
| [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)]. | 2002-03-02 |
|
| Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. | 2002-03 |
|
| Stains, labels and detection strategies for nucleic acids assays. | 2002-03 |
|
| DFT analysis of the activation and breaking of the Mo-N bond in a (mu-nitrido)dimolybdenum complex: is molybdenum tris(thiolate) an elusive intermediate? | 2002-02-25 |
|
| Intrinsic (gas phase) thermodynamic stability of 2-adamantyl cation. Its bearing on the solvolysis rates of 2-adamantyl derivatives. | 2002-02-22 |
|
| A cuboctahedral supramolecular capsule by 4:4 self-assembly of Tris(Zn(II)-cyclen) and trianionic trithiocyanurate in aqueous solution at neutral pH (cyclen=1,4,7,10-tetraazacyclododecane). | 2002-02-15 |
|
| Regiochemistry of the photostimulated reaction of the phthalimide anion with 1-iodoadamantane and tert-butylmercury chloride by the S(RN)1 mechanism. | 2002-02-08 |
|
| The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration. | 2002-02 |
|
| Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway. | 2002-02 |
|
| Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions. | 2002-02 |
|
| Synthesis and optimization of a new family of type 3 17 beta-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry. | 2002-01-31 |
|
| Palladium-catalyzed arylation of malonates and cyanoesters using sterically hindered trialkyl- and ferrocenyldialkylphosphine ligands. | 2002-01-25 |
|
| Effects of the incorporation of IBTM beta-turn mimetics into the dipeptoid CCK(1) receptor agonist PD 170292. | 2002-01-21 |
|
| Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. | 2002-01-15 |
|
| Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. | 2002-01 |
|
| Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection. | 2002-01 |
|
| Iron polynitroporphyrins bearing up to eight beta-nitro groups as interesting new catalysts for H2O2-dependent hydrocarbon oxidation: unusual regioselectivity in hydroxylation of alkoxybenzenes. | 2001-09-21 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:35:25 GMT 2025
by
admin
on
Mon Mar 31 20:35:25 GMT 2025
|
| Record UNII |
PJY633525U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
PJY633525U
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
SUB36875
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
281-23-2
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
DTXSID5022017
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
100000128960
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
D000218
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
DB03627
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
527913
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
9238
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
m1407
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
40519
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
206-001-4
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY | |||
|
ADAMANTANE
Created by
admin on Mon Mar 31 20:35:25 GMT 2025 , Edited by admin on Mon Mar 31 20:35:25 GMT 2025
|
PRIMARY |